![John Higgins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Higgins
Presidente en OMNIAB, INC. .
Fortuna: 14 M $ al 31/10/2024
Perfil
Mr. John L.
Higgins is a Chairman at OmniAb, Inc., a Chief Executive Officer at Metabasis Therapeutics, Inc., an Independent Director at Bio-Techne Corp., a Chairman at Academy of Whole Learning, a Chairman at OmniAb Operations, Inc. and a Chief Executive Officer at CyDex Pharmaceuticals, Inc. He is on the Board of Directors at Pelican Inc and Bio-Techne Corp.
Mr. Higgins was previously employed as a CFO & EVP-Administration & Corporate Development by Connetics Corp., an Independent Director by BioCryst Pharmaceuticals, Inc., a Chairman by CoMentis, Inc., and a Member-Healthcare Banking Team by Dillon, Read & Co., Inc. He also served on the board at Ligand Pharmaceuticals, Inc. and Blue Zones LLC.
He received his undergraduate degree from Colgate University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OMNIAB, INC.
2.22% | 18/06/2024 | 2 623 965 ( 2.22% ) | 11 M $ | 31/10/2024 |
BIO-TECHNE CORPORATION
0.03% | 24/10/2024 | 48 196 ( 0.03% ) | 4 M $ | 31/10/2024 |
Últimas noticias acerca de John Higgins
Cargos activos de John Higgins
| Empresas | Cargo | Inicio |
|---|---|---|
| BIO-TECHNE CORPORATION | Director/Miembro de la Junta | 19/05/2009 |
| PFENEX INC. | Director/Miembro de la Junta | 01/10/2020 |
| OMNIAB, INC. | Presidente | 01/11/2022 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Director Ejecutivo | 01/01/2010 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Presidente | - |
Academy of Whole Learning
 Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Presidente | - |
CyDex Pharmaceuticals, Inc.
 CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Director Ejecutivo | - |
Antiguos cargos conocidos de John Higgins.
| Empresas | Cargo | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director Ejecutivo | 05/12/2022 |
| BIOCRYST PHARMACEUTICALS, INC. | Director/Miembro de la Junta | - |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formación de John Higgins.
| Colgate University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| BIO-TECHNE CORPORATION | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Empresas privadas | 9 |
|---|---|
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
| Dillon, Read & Co., Inc. | Finance |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Blue Zones LLC
 Blue Zones LLC Medical/Nursing ServicesHealth Services Blue Zones LLC provides healthcare services. The company was founded by Dan Buettner and is headquartered in Minneapolis, MN. | Health Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
Academy of Whole Learning
Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Commercial Services |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John Higgins
